Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share

The changes below will take effect on Nasdaq Copenhagen as per 10 October 2024.



ISIN          DK0061155009                       
--------------------------------------------------------------------------------
Name:         Pharma Equity Group                   
--------------------------------------------------------------------------------
Volume before change: 1,022,963,883 shares of DKK 1 each (DKK 1,022,963,883)  
--------------------------------------------------------------------------------
Change:        DKK 920,667,494.70                    
--------------------------------------------------------------------------------
Volume after change:  1,022,963,883 shares of DKK 0.10 each (DKK        
            102,296,388.30)                     
--------------------------------------------------------------------------------
New face value:    DKK 0.10                         
--------------------------------------------------------------------------------
Short name:      PEG                           
--------------------------------------------------------------------------------
Orderbook ID:     21613                          
--------------------------------------------------------------------------------





For further information, please contact: Surveillance, tel. +45 33 93 33 66

5 heiße Wetten für den Jahresendspurt!

Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Hier klicken

Zeit	Aktuelle Nachrichten
15.11.	Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 2024	Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November... ► Artikel lesen
23.10.	Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.	Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement... ► Artikel lesen
14.10.	Major shareholder announcement - Pharma Equity Group A/S
14.10.	Pharma Equity Group A/S: Managers' transactions
11.10.	Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue	The share capital of Pharma Equity Group A/S has been increased. The admittance to trading and official listing of new shares will take effect as per 16 October 2024 in the ISIN below. ISIN ... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.11.

Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 2024

Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November...
► Artikel lesen

23.10.

Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement...
► Artikel lesen

14.10.

Major shareholder announcement - Pharma Equity Group A/S

14.10.

Pharma Equity Group A/S: Managers' transactions

11.10.

Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue

The share capital of Pharma Equity Group A/S has been increased. The admittance to trading and official listing of new shares will take effect as per 16 October 2024 in the ISIN below. ISIN ...
► Artikel lesen

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche

PHARMA EQUITY GROUP A/S

Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share